TY  - GEN
AU  - Weisberg,Alec D
AU  - Albornoz,Francisco
AU  - Griffin,Jane P
AU  - Crandall,David L
AU  - Elokdah,Hassan
AU  - Fogo,Agnes B
AU  - Vaughan,Douglas E
AU  - Brown,Nancy J
TI  - Pharmacological inhibition and genetic deficiency of plasminogen activator inhibitor-1 attenuates angiotensin II/salt-induced aortic remodeling
SN  - 1524-4636
PY  - 2005///0802
KW  - Acetates
KW  - pharmacology
KW  - Administration, Oral
KW  - Angiotensin II
KW  - toxicity
KW  - Animals
KW  - Antigens, Differentiation
KW  - biosynthesis
KW  - Aorta
KW  - drug effects
KW  - Aortic Diseases
KW  - chemically induced
KW  - Blood Pressure
KW  - Chemokine CCL2
KW  - Collagen Type I
KW  - Collagen Type III
KW  - Drug Evaluation, Preclinical
KW  - Fibronectins
KW  - Fibrosis
KW  - Gene Expression Regulation
KW  - Glomerulosclerosis, Focal Segmental
KW  - Heart
KW  - Hypertrophy, Left Ventricular
KW  - Indoleacetic Acids
KW  - Indoles
KW  - Kidney
KW  - Male
KW  - Mice
KW  - Mice, Inbred C57BL
KW  - Mice, Knockout
KW  - Myocardium
KW  - metabolism
KW  - Nephrectomy
KW  - Osteopontin
KW  - Plasminogen Activator Inhibitor 1
KW  - deficiency
KW  - RNA, Messenger
KW  - Random Allocation
KW  - Sialoglycoproteins
KW  - Single-Blind Method
KW  - Sodium Chloride, Dietary
N1  - Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S
UR  - https://doi.org/10.1161/01.ATV.0000152356.85791.52
ER  -